<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50202">Naringenin</z:chebi> has been shown to display various biological effects such as <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, anticancer, anti-inflammatory, and antiviral activities </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="38747">Taxifolin</z:chebi> inhibits the production of <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>-induced <z:chebi fb="11" ids="26333">prostaglandin</z:chebi>Â E, and <z:chebi fb="0" ids="5202">fustin</z:chebi> suppresses the activity of acetylcholinesterase </plain></SENT>
<SENT sid="2" pm="."><plain>They <z:hpo ids='HP_0000001'>all</z:hpo> belong to <z:chebi fb="0" ids="5070">flavanone</z:chebi> which is a class of <z:chebi fb="5" ids="47916">flavonoids</z:chebi> with a C6-C3-C6 skeleton </plain></SENT>
<SENT sid="3" pm="."><plain>Since the anticancer activities of <z:chebi fb="0" ids="5070">flavanone</z:chebi> derivatives have rarely been reported, we examined the effects of 26 flavanone derivatives on HCT116 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Our results suggest that <z:chebi fb="0" ids="5070">flavanone</z:chebi> derivatives control the expression of cell cycle regulatory proteins, which blocks G1 cell cycle progression and inhibits the clonogenicity of HCT116 cells </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, in order to design <z:chebi fb="0" ids="5070">flavanone</z:chebi> derivatives that show better anticancer activity, structure-activity relationships were examined </plain></SENT>
</text></document>